Market Research Report Store United States Adoptive Cell Therapy for Cancer Tre | Page 3
1 Adoptive Cell Therapy for Cancer Treatment Overview
1.1 Product Overview and Scope of Adoptive Cell Therapy for Cancer Treatment
1.2 Classification of Adoptive Cell Therapy for Cancer Treatment by Product Category
1.2.1 United States Adoptive Cell Therapy for Cancer Treatment Market Size (Sales
Volume) Comparison by Type (2012-2022)
1.2.2 United States Adoptive Cell Therapy for Cancer Treatment Market Size (Sales
Volume) Market Share by Type (Product Category) in 2016
1.2.3 Surgery
1.2.4 Chemotherapy
1.2.5 Radiotherapy
1.3 United States Adoptive Cell Therapy for Cancer Treatment Market by Application/End
Users
1.3.1 United States Adoptive Cell Therapy for Cancer Treatment Market Size
(Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Autologous adoptive T cell therapy
1.3.3 Allogeneic Adoptive T cell therapy
1.4 United States Adoptive Cell Therapy for Cancer Treatment Market by Region
1.4.1 United States Adoptive Cell Therapy for Cancer Treatment Market Size (Value)
Comparison by Region (2012-2022)
1.4.2 The West Adoptive Cell Therapy for Cancer Treatment Status and Prospect
(2012-2022)
1.4.3 Southwest Adoptive Cell Therapy for Cancer Treatment Status and Prospect
(2012-2022)
1.4.4 The Middle Atlantic Adoptive Cell Therapy for Cancer Treatment Status and
Prospect (2012-2022)
1.4.5 New England Adoptive Cell Therapy for Cancer Treatment Status and Prospect
(2012-2022)
1.4.6 The South Adoptive Cell Therapy for Cancer Treatment Status and Prospect
(2012-2022)